Human recessive osteopetrosis: New understanding of osteoclast function through molecular and functional analysis of a rare genetic bone disease

Osteologie

Volumn 18, Issue 4, 2009, Pages 260-267

  Helfrich, Miep H ^a   Perdu, B ^b   Coxon, F ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acidification; Endosomal trafficking; Osteoclast; Osteopetrosis

Indexed keywords

EID: 78651519100     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619909     Document Type: Short Survey

References (40)

1. Steward CG. Neurological aspects of osteopetrosis. Neuropathol Appl Neurobiol 2003; 29: 87-97. (Pubitemid 36408327)
2. Benichou OD, Laredo JD, de Vernejoul MC. Type II autosomal dominant osteopetrosis (Albers-Schönberg disease): clinical and radiological manifestations in 42 patients. Bone 2000; 26: 87-93.
3. Del Fattore A, Peruzzi B, Rucci N et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 2006; 43: 315-325.
4. Balemans W, Patel N, Ebeling M et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 2002; 39: 91-97. (Pubitemid 34146376)
5. Balemans W, Ebeling M, Patel N et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 2001; 10: 537-543. (Pubitemid 32184286)
6. Van Wesenbeeck L, Cleiren E, Gram J et al. Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions withan increased bone density. Am J Hum Genet 2003; 72: 763-771. (Pubitemid 36255977)
7. Yadav VK, Ryu JH, Suda N et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008; 135: 825-837.
8. Cleiren E, Benichou O, Van Hul E et al. Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 2001; 10: 2861-2867. (Pubitemid 34030917)
9. Helfrich MH. Osteoclast diseases. Microsc Res Tech 2003; 61: 514-532. (Pubitemid 36890584)
10. Villa A, Guerrini MM, Cassani B et al. Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor. Calcif Tissue Int 2009; 84: 1-12.
11. Van Wesenbeeck L, Van Hul W. Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology. Crit Rev Eukaryot Gene Expr 2005; 15: 133-162. (Pubitemid 41277408)
12. Sly WS, Hewett-Emmett D, Whyte MP et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A 1983; 80: 2752-2756. (Pubitemid 13093387)
13. Roth DE, Venta PJ, Tashian RE, Sly WS. Molecular basis of human carbonic anhydrase II deficiency. Proc Natl Acad Sci U S A 1992; 89: 1804-1808.
14. Hu PY, Ernst AR, Sly WS et al. Carbonic anhydrase II deficiency: single-base deletion in exon 7 is the predominant mutation in Caribbean Hispanic patients. Am J Hum Genet 1994; 54: 602-608. (Pubitemid 24089599)
15. Frattini A, Orchard PJ, Sobacchi C et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25: 343-346. (Pubitemid 30437326)
16. Kornak U, Schulz A, Friedrich W et al. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet 2000; 9: 2059-2063. (Pubitemid 30642671)
17. Toyomura T, Oka T, Yamaguchi C et al. Three subunit a isoforms of mouse vacuolar H(+)-ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J Biol Chem 2000; 275: 8760-8765. (Pubitemid 30180229)
18. Kornak U, Kasper D, Bosl MR et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104: 205-215. (Pubitemid 32174837)
19. Chalhoub N, Benachenhou N, Rajapurohitam V et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 2003; 9: 399-406. (Pubitemid 36460073)
20. Pangrazio A, Poliani PL, Megarbane A et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J Bone Miner Res 2006; 21: 1098-1105. (Pubitemid 43962838)
21. Lange PF, Wartosch L, Jentsch TJ. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006; 440: 220-223. (Pubitemid 43372100)
22. Ramirez A, Faupel J, Goebel I et al. Identification of a novel mutation in the coding region of the greylethal gene OSTM1 in human malignant infantile osteopetrosis. Hum Mutat 2004; 23: 471-476. (Pubitemid 38569220)
23. Van Wesenbeeck L., Odgren PR, Coxon FP et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 2007; 117: 919-930. (Pubitemid 46556748)
24. Del Fattore A, Fornari R, Van WL et al. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts. J Bone Miner Res 2008; 23: 380-391. (Pubitemid 351304668)
25. Sobacchi C, Frattini A, Guerrini MM et al. Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet 2007; 39: 960-962. (Pubitemid 47185178)
26. Guerrini MM, Sobacchi C, Cassani B et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008; 83: 64-76. (Pubitemid 351916706)
27. Helfrich MH, Aronson DC, Everts V et al. Morphologic features of bone in human osteopetrosis. Bone 1991; 12: 411-419.
28. Karsdal MA, Martin TJ, Bollerslev J et al. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 2007; 22: 487-494. (Pubitemid 47457424)
29. Guerrini MM, Sobacchi C, Cassani B et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemiadue to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008; 83: 64-76. (Pubitemid 351916706)
30. Del Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone 2008; 42:1 9-29.
31. Teti A, Migliaccio S, Taranta A et al. Mechanisms of osteoclast dysfunction in human osteopetrosis: abnormal osteoclastogenesis and lack of osteoclastspecific adhesion structures. J Bone Miner Res 1999; 14: 2107-2117. (Pubitemid 30026960)
32. Blair HC, Yaroslavskiy BB, Robinson LJ et al. Osteopetrosis with micro-lacunar resorption because of defective integrin organization. Lab Invest 2009; 89: 1007-1017.
33. Walker DG. Osteopetrosis cured by temporary parabiosis. Science 1973; 180: 875.
34. Walker DG. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science 1975; 190: 784-785.
35. Coccia PF, Krivit W, Cervenka J et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701-708. (Pubitemid 10132096)
36. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996; 273: 1236-1238.
37. Gauthier JY, Chauret N, Cromlish W et al. The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorg Med Chem Lett 2008; 18: 923-928. (Pubitemid 351179363)
38. Schaller S, Henriksen K, Sorensen MG, Karsdal MA. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment. Drug News Perspect 2005; 18: 489-495. (Pubitemid 43094116)
39. Sørensen MG, Henriksen K, Neutzsky-Wulff AV et al. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption. J Bone Miner Res 2007; 22: 1640-1648. (Pubitemid 351229334)
40. Rivollier A, Mazzorana M, Tebib J et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 2004; 104: 4029-4037. (Pubitemid 39620153)